E³ - ECR Master Class

E³ 1626 - Whole-body MRI (and PET/MRI)

Lectures

1
E³ 1626 - A. Metastatic bone prostate cancer

E³ 1626 - A. Metastatic bone prostate cancer

14:35F. Lecouvet, Brussels / BE

Learning Objectives
1. To define imaging strategies in newly diagnosed, recurrent, and advanced disease.
2. To learn to use MET-RADS-P guidelines for whole-body MRI acquisition, reading, and response assessment.
3. To illustrate recent therapeutic advances: i.e. oligometastatic disease and precision medicine approaches.

2
E³ 1626 - B. Multiple myeloma

E³ 1626 - B. Multiple myeloma

14:19I. Lupescu, Bucharest / RO

Learning Objectives
1. To become aware of the value of whole-body MRI in myeloma.
2. To understand current imaging protocols.
3. To learn about its roles: detect, monitor, and provide prognostic information.

3
E³ 1626 - C. Lymphoma

E³ 1626 - C. Lymphoma

15:35M. Mayerhöfer, Vienna / AT

Learning Objectives
1. To introduce the role of whole-body MRI and PET/MRI for imaging lymphoma subtypes.
2. To know its value for detection, assessment of response, and prognosis.
3. To understand the current advantages and limitations of whole-body MRI and PET/MRI.

E³ 1626-1
15 min
A. Metastatic bone prostate cancer
Frédéric Lecouvet, Brussels / Belgium
Learning Objectives
1. To define imaging strategies in newly diagnosed, recurrent, and advanced disease.
2. To learn to use MET-RADS-P guidelines for whole-body MRI acquisition, reading, and response assessment.
3. To illustrate recent therapeutic advances: i.e. oligometastatic disease and precision medicine approaches.
E³ 1626-2
15 min
B. Multiple myeloma
Ioana Gabriela Lupescu, Bucharest / Romania
Learning Objectives
1. To become aware of the value of whole-body MRI in myeloma.
2. To understand current imaging protocols.
3. To learn about its roles: detect, monitor, and provide prognostic information.
E³ 1626-3
15 min
C. Lymphoma
Marius E. Mayerhöfer, Wien / Austria
Learning Objectives
1. To introduce the role of whole-body MRI and PET/MRI for imaging lymphoma subtypes.
2. To know its value for detection, assessment of response, and prognosis.
3. To understand the current advantages and limitations of whole-body MRI and PET/MRI.
10 min
Live Q&A

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.